Skip to content

All Press Releases

Pila Pharma invites to After-Work investor meetings

Malmö, 7 November 2023 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) hereby invites you to an exciting evening of conversation when we host an after-work investor event near you! CEO & Founder Dorte X. Gram will elaborate on Pila Pharma and its innovative pill-treatment for obesity, diabetes and other related disorders. In the Q&A…

Read more

PILA PHARMA PUBLISHES INTERIM REPORT (1 July – 30 September 2023)

Malmö, 25 October, 2023 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s interim report for the period July – September 2023. The report can be found on the Company´s website: https://pilapharma.com/investors/finansiell-information/. SUMMARY OF INTERIM REPORT THIRD QUARTER (1 JULY – 30 SEPTEMBER 2023) Operating income amounted to TSEK 0 (281) The…

Read more

PILA PHARMA’S BOARD OF DIRECTORS HAS RESOLVED TO CARRY OUT A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 26.2 MILLION

Malmö, 25 October, 2023 Download the press release as PDF here NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD…

Read more

Contact us

Subscription for press releases
Back To Top